Overview

Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
Maturity level of dendritic cells (DC) plays a pivotal role in initiating and regulating autoimmunity. In Graves' disease (GD), DCs have more active immune responses than those in healthy subjects. Our previous study demonstrated immunoregulatory effects of in vitro 1,25-D3 on maturation of DC in GD patients. This study aims to evaluate the effect of oral 1α-D3 on DC maturation in GD patients.
Phase:
Phase 2
Details
Lead Sponsor:
Dr Cipto Mangunkusumo General Hospital
Collaborator:
Indonesia University
Treatments:
Alfacalcidol
Dihydroxycholecalciferols
Hydroxycholecalciferols